ClinicalTrials.gg
Not yet recruitingNCT07356141Updated Oct 6, 2026

Monitoring Occupational Dental Stress Using Apple Watch

An observational study in Occupational Stress, sponsored by University of Illinois at Chicago. Not yet recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by University of Illinois at Chicago · Observational

How we know

Updated Oct 6, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Occupational Stress with a site in United States — 10 open to participants now, 13 under way, none of them phase 3. Occupational Stress · United States.

Started
2027
with 1 other
Observational
7 of 61
4 open now
Primary completion
2028-06
later than 8 of 12 live
Registered
54th of 61
by date
Lead sponsor
2 of 61
University of Illinois at Chicago

Among the 61 studies in Occupational Stress with a site in United States, this one is one of 2 that started in 2027, is one of 7 observational ones, reaches primary completion later than 8 of the 12 other live ones, and was the 54th registered.

Occupational Stress

238 studies on the registry are indexed under Occupational Stress; 64 are open to participants now.

Browse Occupational Stress studies →

Open to participants now

10 of the 61 studies in Occupational Stress with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 33 Occupational Stress studies recruiting now, 17 (52%) set no upper age limit and 13 (39%) stop at 75 or younger; 4 take children under 18; 25 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Occupational Stress with a site in United States, or all of them as a file.
02

Study summary

  • This study will enroll 10 dental students (primary subjects) and up to 200 patients (secondary subjects), approximately 10 special-needs and 10 non-special-needs encounters per student, totaling about 200 treatment sessions.
  • Students will wear an Apple Watch to continuously monitor heart rate (HR) during routine care. The Apple Watch contains built-in physiological sensors that automatically record heart rate and heart rate variability. These data are stored locally in the Apple Health app on a study-designated iPhone that is assigned for the research and handled solely by the Principal Investigator (PI). No real-time transmission or cloud-based sharing occurs during data recording. No additional apps, accounts, or third-party software are used. At designated intervals, the PI will use the health app's built-in "Export Health Data" function on the study iPhone. This function generates a ZIP file containing an export.xml file with sensor-recorded data. The PI will then upload the ZIP file from the study iPhone directly to a secure, university-approved UI Box Health Data Folder designated for the study. No research account will be set up for this purpose.
  • A trained observer will record start/stop timepoints of procedure phases (e.g., seating, anesthesia start, operative phase, dismissal) to align with HR signals and will document only minimal patient variables needed for analysis: behavior/cooperation score (e.g., Frankl), sedation status, and broad procedure category (e.g., preventive, restorative, surgical).
  • Each dental student will complete the Perceived Stress Questionnaire (PSQ) only once at the beginning of the study to stablish a baseline measure of stress. The Questionnaire takes approximately 5 minutes to complete. Students do not need to complete the PSQ for each patient encounter. Student HR data and permitted minimal patient variables will be coded and de-identified, stored securely in UI Box Health Data Folder, and analyzed to compare special-needs vs non-special-needs encounters and to evaluate associations between student HR and the listed patient factors. No additional patient identifiers or PHI will be collected beyond what is specified above.
03

Conditions studied

  • Occupational Stress

Browse trials for

Keywords

  • stress
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Primary Subjects - Dental Students:

Ten (10) dental students enrolled at the University of Illinois Chicago (UIC) College of Dentistry will participate. These students will provide routine clinical care to both special needs and non-special needs patients as part of their standard educational and clinical responsibilities.

Secondary Subjects - Patients Receiving Care:

Approximately 200 patients will be observed during these clinical sessions, including both special needs patients treated in the Inclusive Care Clinic (ICC) and non-special needs patients treated in other UIC dental clinics. Special needs patients and/or their legally authorized representatives (LARs) will provide consent, and, when appropriate, patients will provide assent.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Students (primary subjects) inclusion criteria: After IRB approval, non-supervisory staff or research team members will invite potential participants via UIC email/listservs. Interested students will be screened confirming: (a) good academic standing and current clinical assignment, (b) routine provision of care to both special-needs and non-special needs patients during the data-collection window, (c) willingness to wear an Apple Watch during sessions and complete baseline/end PSQ, and (d) absence of medical/dermatologic conditions that would preclude safe/accurate wrist-worn monitoring. Screening and consent occur privately and outside evaluative contexts.
  • Patient (secondary subjects) Inclusion criteria: Patients will be screened at the point of care when already scheduled with a participating student. A pre-visit check confirms capacity to consent (or availability of a legally authorized representative/parent/guardian). For minors and/or special needs patients, LAR permission will be obtained in addition to assent to the research. The following criteria will be considered:
  • Minors and/or Special-needs patients who are scheduled for standard clinical care with a participating student during the study period may be enrolled as secondary subjects provided that their parent/guardian or legally authorized representative (LAR) grants permission during the consent process and the patient assents to the research when appropriate.
  • Adult Patients with capacity who are scheduled for standard clinical care with a participating student during the study period may be enrolled as secondary subjects provided that are willing to provide .
  • Willing to allow an observer and collection of minimal visit-level variables (behavior/cooperation score, sedation status, broad procedure category).
  • Patients and/or their parent(s), guardian(s), or legally authorized representative(s) providing consent must be able to understand and communicate in English.

Exclusion criteria

Exclusion Criteria:

  • Students (primary subjects) Exclusion criteria:
  • Not assigned to patient-care rotations during the study window.
  • Known dermatologic, cardiovascular, neurologic, or other medical conditions that would interfere with safe or accurate HR monitoring or tolerability of a wrist device.
  • Unwilling or unable to provide consent or follow procedures.
  • Patients (secondary subjects) Exclusion criteria:
  • Declines consent/permission/assent or withdraws at any time.
  • Prisoners or individuals under custodial supervision.
  • Pregnant women
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (estimated)
Patient registry
No

Groups and cohorts

  • patient with special needs
  • Patients with capability
06

What researchers measure

Primary outcomes

  1. Heart rate changes in dental students during dental procedures

    Time frame: During each dental treatment session per session

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2027; primary completion for Jun 2028, 10 months later.

Of 27 observational studies under Occupational Stress, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 41. This study's planned 10 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: start Aug 2026 → Aug 2027, primary completion Jun 2027 → Jun 2028 and completion Oct 2027 → Oct 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2026
First posted
Jan 21, 2026
StartEst.
Aug 1, 2027was Aug 2026
Primary completionEst.
Jun 1, 2028was Jun 2027
CompletionEst.
Oct 2029was Oct 2027
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 1, 2026→Aug 1, 2027
Oct 6, 2026
Primary completion
Jun 1, 2027→Jun 1, 2028
Oct 6, 2026
Study completion
Oct 2027→Oct 2029
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    Start date Aug 1, 2026→Aug 1, 2027
    Primary completion Jun 1, 2027→Jun 1, 2028
    Study completion Oct 2027→Oct 2029
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07356141
Responsible party
Shlomo Elbahary (Clinical Associate Professor, University of Illinois at Chicago) — Principal investigator
First posted
Jan 21, 2026
Start date
Aug 1, 2027 (estimated)
Primary completion
Jun 1, 2028 (estimated)
Completion
Oct 2029 (estimated)
Last update
Oct 6, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion